Tudor Investment Corp
KPTI icon

Tudor Investment Corp’s Karyopharm Therapeutics KPTI Stock Holding History

Tudor Investment Corp’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,922
Closed -$95.1K – 3987
2025
Q4 		$95.1K Buy
+12,922
New +$79K ﹤0.01% 3384
2023
Q2 		– Sell
-10,082
Closed -$588K – 2701
2023
Q1 		$588K Buy
10,082
+2,098
+26% +$104K 0.01% 1524
2022
Q4 		$407K Buy
7,984
+3,980
+99% +$276K 0.01% 1721
2022
Q3 		$328K Buy
4,004
+370
+10% +$27.6K 0.01% 1722
2022
Q2 		$246K Buy
+3,634
New +$333K 0.01% 1690
2022
Q1 		– Sell
-13,902
Closed -$1.34M – 2373
2021
Q4 		$1.34M Buy
13,902
+1,040
+8% +$104K 0.02% 846
2021
Q3 		$1.12M Buy
12,862
+7,477
+139% +$776K 0.02% 1076
2021
Q2 		$834K Sell
5,385
-173
-3% -$25.1K 0.02% 937
2021
Q1 		$877K Buy
+5,558
New +$1.17M 0.02% 901
2020
Q4 		– Sell
-2,161
Closed -$473K – 1485
2020
Q3 		$473K Buy
+2,161
New +$529K 0.02% 835
2020
Q1 		– Sell
-3,591
Closed -$1.03M – 1196
2019
Q4 		$1.03M Buy
+3,591
New +$779K 0.05% 484
2018
Q2 		– Sell
-810
Closed -$163K – 1147
2018
Q1 		$163K Sell
810
-712
-47% -$142K 0.01% 893
2017
Q4 		$219K Buy
1,522
+317
+26% +$50.9K 0.01% 935
2017
Q3 		$198K Buy
1,205
+200
+20% +$28.6K 0.01% 964
2017
Q2 		$136K Buy
+1,005
New +$149K ﹤0.01% 935
2017
Q1 		– Sell
-775
Closed -$109K – 1470
2016
Q4 		$109K Sell
775
-313
-29% -$42.3K ﹤0.01% 1296
2016
Q3 		$159K Buy
+1,088
New +$131K ﹤0.01% 1292
2014
Q3 		– Sell
-1,000
Closed -$698K – 1425
2014
Q2 		$698K Buy
+1,000
New +$465K 0.03% 362

Other funds holding KPTI

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Tudor Investment Corp's KPTI Position: Q1 2026 in Review

Tudor Investment Corp sold out of Karyopharm Therapeutics (KPTI) in Q1 2026, closing a stake of 12,922 shares — an estimated $95.1K sold.

Tudor Investment Corp first reported a position in KPTI in Q2 2014 and held it in 18 quarters. The position peaked at $1.34M in Q4 2021. 77 funds tracked by Wall St. Rank hold KPTI as of Q1 2026.

  • Tudor Investment Corp reported no remaining Karyopharm Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 12,922 Karyopharm Therapeutics shares in Q1 2026, an estimated $95.1K.
  • Tudor Investment Corp first reported a position in Karyopharm Therapeutics in Q2 2014 and held it in 18 quarters.
  • Tudor Investment Corp's Karyopharm Therapeutics position peaked at $1.34M in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.